FDA’s Woodcock on authorizing emergency use for hydroxychloroquine: ‘We did the best we could’

Janet Woodcock, the head of the FDA Center for Drug Evaluation and Research, interviews to talk about Emergency Use Authorization as well as the steps her division is taking to maintain quality control standards at manufacturing plants and keeping advisory committee reviews on track. Learn more here.

Article by Ed Silverman